Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publications List of Dr. Roshan Kamal Topno

 

23.

Kumar R, Pandey K, Sahoo GC, Das S, Das V, Topno RK and Das P. Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis. Mater Sci Eng C Mater Biol Appl. 2017 Jun 1;75:1465-1471. doi: 10.1016/j.msec.2017.02.145. Epub 2017 Mar 4.

22.

Dikhit MR, Amit A, Singh AK, Kumar A, Mansuri R, Sinha S, Topno RK, Mishra R, Das VNR, Pandey K, Sahoo GC, Ali V, Bimal S and Das P. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC). Parasite Immunol. 2017 Sep;39(9). doi: 10.1111/pim.12451. Epub 2017 Jul 28.

21.

Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.

20.

Siddiqui NA, Rabidas VN, Sinha SK, Verma RB, Pandey K, Singh VP, Ranjan A, Topno RK, Lal CS, Kumar V, Sahoo GC, Sridhar S, Pandey A and Das P. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison. PLoS Negl Trop Dis. 2016; 10(9): e0004970. doi: 10.1371/journal.pntd.0004970.
19.
Dikhit MR, Ansari MY, Vijaymahantesh, Kalyani, Mansuri R, Sahoo BR, Dehury B, Amit A, Topno RK, Sahoo GC, Ali V, Bimal S and Das P. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development. Infect Genet Evol. 2016; 45: 187-197. doi: 10.1016/j.meegid.2016.08.037.

18.

Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P and Pandey K. Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series. Pathog Glob Health. 2016; 110(7-8): 326-329. No abstract available.

17.

Kumar R, Sahoo GC, Pandey K, Das VN, Topno RK, Ansari MY, Rana S and Das P. Development of PLGA-PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis. Mater Sci Eng C Mater Biol Appl. 2016; 59: 748-573. doi: 10.1016/j.msec.2015.10.083. (Epub 2015 Oct 29).

16.

Sahoo GC, Ansari MY, Rana SP, Dikhit MR, Topno RK, Pandey K and Das P. Molecular Modeling and Ligand-Protein Interaction of N-Protein of Chandipura Virus. Letters in Drug Design & Discovery. 2014; 11(2): 211-221.
 

15.

Singh D, Pandey K, Das VN, Das S, Verma N, Ranjan A, Lal CS, Topno KR, Singh SK, Verma RB, Kumar A, Sardar AH, Purkait B and Das P. Evaluation of rK-39 Strip Test Using Urine for Diagnosis of Visceral Leishmaniasis in an Endemic Region of India.  Am Am J Trop Med Hyg. 2013; 88(2): 222-226. doi: 10.4269/ajtmh.2012.12-0489. (Epub 2012 Nov 13).

14.

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

13.

Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N and Das P. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg, 2011; 105(11): 661-666. (Epub 2011 Sep 25).

12.

Sarnoff R, Desai J, Desjeux P, Mittal A, Topno R, Siddiqui NA, Pandey A, Sur D and Das P. Visceral leishmaniasis supplement: the economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India.  Trop Med Int Health, 2010 May 6. [Epub ahead of print]

11.

Das P, Samuels S, Desjeux P, Mittal A, Topno R, Siddiqui NA, Sur D, Pandey A and Sarnoff R. Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Medicine and International Health ,2010; 15(suppl. 2):1-8.

10.

Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, Ravidas VN, Kumar N, Pandey K and Das P. Estimation of under reporting of Visceral Leishmaniasis cases in Bihar, India. American Journal of Tropical Medicine Hygiene, 2010; 82(1): 9-11.


09.

Topno RK, Das VN, Ranjan A, Pandey K, Singh D, Kumar N, Siddiqui NA, Singh VP, Kesari S, Kumar N, Bimal S, Kumar AJ, Meena C, Kumar R and Das P. Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in bihar, India. Am J Trop Med Hyg, 2010; 83(3): 502-506.

08.

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


07.

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of  mphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.


06.

Singh D, Pandey K, Das VN, Das S, Kumar S, Topno RK and Das P. Novel noninvasive method for diagnosis of visceral leishmaniasis by rK39 testing of sputum samples. J Clin Microbiol. 2009; 47(8): 2684-2685.


05.

Pandey k, Sinha PK, Das VN, Nawin Kumar,.Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.


04.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol, 2008; 102(2): 185-188.

03.

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

02.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P and Bhattacharya SK. Miltefosine in the Treatment of a case of Visceral Leishmaniasis with Renal Dysfunction. Ann Trop Med Parasitol, 2007; 101(7): 649-651.

01.

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg, 2007; 77(3): 560 – 561.